Cold Spring Harbor Laboratory Advances in Brain Tumor Research & Therapy 2025

• Target Audience: neuroscientists, neuro-oncologists, clinical researchers
• Sample video: contact me for sample video
• Information:

What You Will Learn

Emerging insights in clinical care, imaging, pathology, surgery, radiation oncology, and therapeutic innovation for brain tumors

Foundational and translational knowledge in cancer genetics, pediatric brain tumors, and mechanisms of tumor development and progression

Advances in gliomas, meningiomas, medulloblastoma, ependymoma, DIPG, and brain metastases

Cutting-edge research in mouse models, genomics, proteogenomics, metabolism, the tumor microenvironment, angiogenesis, immunology, and preclinical drug development

Strategies for clinical translation including trial design, overcoming blood-brain barrier challenges, and optimizing therapeutic interventions

Event Details

Event: Cold Spring Harbor Laboratory – Advances in Brain Tumor Research & Therapy 2025

Highlights: Small-group setting promoting mutual exchange between early-career investigators and established experts; hosted keynotes and diverse speaker lineup from top institutions

Who Should Attend

Neuroscientists, neuro-oncologists, clinical researchers, graduate students, postdocs, and clinicians who focus on brain tumor biology, translating basic science, and advancing therapeutic strategies.

Why Attend

• Topics:

Clinical Aspects of Brain Tumors

Pathology / Imaging / Population biology / Quality of Life / Surgery / Radiation oncology / Medical therapies

Genetics and Developmental Biology

Cancer Genetics / Pediatric brain tumors / Cancer neuroscience

Gliomas and Nervous System Disorders

Gliomas / Meningiomas / Ependymomas / Medulloblastomas / ATRT / Brain metastases / Diffuse Intrinsic Pontine Glioma (DIPG)

Mouse Models and Genomics

Mouse models/ Genomics / Proteogenomics / Large datasets

Metabolism

Metabolic reprogramming / RNA biology / Lipid biology

Microenvironment, Angiogenesis and Immunology

Angiogenesis / Engineered T cell vs checkpoint inhibition / Monocytes

Drug Development and Preclinical Studies

Drug design / Drug screening / Preclinical modeling / Blood brain barrier

Therapeutics and Clinical Trials

Trial design / Heterogeneity